Simvastatin–Fluconazole Causing Rhabdomyolysis

Abstract

Patients receiving statins who have cancer may receive azole antifungals and other drugs that inhibit CYP3A4 during treatment, predisposing them to toxicity. These patients should therefore be monitored closely for drug interactions.